Post-acute sequelae of SARS-CoV-2 are becoming an increasing concern for many patients with a history of COVID-19 infection. Moreover, these sequelae are often nonpulmonary in nature. In this Q&A, Dr...
Post-acute sequelae of SARS-CoV-2 are becoming an increasing concern for many patients with a history of COVID-19 infection. Moreover, these sequelae are often nonpulmonary in nature. In this Q&A, Dr...
Post-acute sequelae of SARS-CoV-2 are becoming an increasing concern for many patients with a history of COVID-19 infection. Moreover, these sequelae are often nonpulmonary in nature. In this Q&A, Dr...
As the COVID-19 vaccines are distributed across the United States, questions arise around vaccine hesitancy, local and state guidelines, and supply and demand. In this Q&A, Dr Evans addresses our...
As the COVID-19 vaccines are distributed across the United States, questions arise around vaccine hesitancy, local and state guidelines, and supply and demand. In this Q&A, Dr Evans addresses our...
As the COVID-19 vaccines are distributed across the United States, questions arise around vaccine hesitancy, local and state guidelines, and supply and demand. In this Q&A, Dr Evans addresses our...
As the COVID-19 vaccines are distributed across the United States, questions arise around vaccine hesitancy, local and state guidelines, and supply and demand. In this Q&A, Dr Evans addresses our...
Asthma is a common comorbidity of atopic dermatitis (AD). A recent review and meta-analysis revealed the prevalence and the association between AD and asthma. Study author Jacob P. Thyssen, MD, PhD, DmSci,...
In this Q&A, Dr Machado answers our questions about the impact that biologic disease-modifying antirheumatic drugs have in axial spondyloarthritis remission.
In this Q&A, Dr Machado answers our questions about the impact that biologic disease-modifying antirheumatic drugs have in axial spondyloarthritis remission.
